Literature DB >> 17872882

St John's wort versus paroxetine for depression.

Jane Jurcic1, Jennifer A Pereira, Devon Kavanaugh.   

Abstract

Entities:  

Year:  2007        PMID： 17872882      PMCID： PMC2234633     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  9 in total

1.  Clinical guidelines for the treatment of depressive disorders.

Authors: 
Journal:  Can J Psychiatry       Date:  2001-06       Impact factor: 4.356

Review 2.  Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.

Authors:  Steve MacGillivray; Bruce Arroll; Simon Hatcher; Simon Ogston; Ian Reid; Frank Sullivan; Brian Williams; Iain Crombie
Journal:  BMJ       Date:  2003-05-10

3.  Complementary and alternative medicine use among adults: United States, 2002.

Authors:  Patricia M Barnes; Eve Powell-Griner; Kim McFann; Richard L Nahin
Journal:  Adv Data       Date:  2004-05-27

4.  Systematic review and guide to selection of selective serotonin reuptake inhibitors.

Authors:  J G Edwards; I Anderson
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

Review 5.  St John's wort for depression: meta-analysis of randomised controlled trials.

Authors:  Klaus Linde; Michael Berner; Matthias Egger; Cynthia Mulrow
Journal:  Br J Psychiatry       Date:  2005-02       Impact factor: 9.319

6.  Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.

Authors:  Jonathan RT Davidson; Kishore M Gadde; John A Fairbank; K Ranga Rama Krishnan; Robert M Califf; Cynthia Binanay; Corette B Parker; Norma Pugh; Tyler D Hartwell; Benedetto Vitiello; Louise Ritz; Joanne Severe; Jonathan O Cole; Charles de Battista; P Murali Doraiswamy; John P Feighner; Paul Keck; Jeffrey Kelsey; Khae-Ming Lin; Peter D Londborg; Charles B Nemeroff; Alan F Schatzberg; David V Sheehan; Ram K Srivastava; Leslie Taylor; Madhukar H Trivedi; Richard H Weisler
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

7.  Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations.

Authors:  Andrew H Draves; Scott E Walker
Journal:  Can J Clin Pharmacol       Date:  2003

8.  Natural health product use in Canada.

Authors:  Leticia Troppmann; Timothy Johns; Katherine Gray-Donald
Journal:  Can J Public Health       Date:  2002 Nov-Dec

Review 9.  The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment.

Authors:  D L Musselman; D L Evans; C B Nemeroff
Journal:  Arch Gen Psychiatry       Date:  1998-07
  9 in total
  2 in total

1.  Evaluation of Pharmaceutical Products of St. John's Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial.

Authors:  Sirus Pakseresht; Hatam Boustani; Mohammad Ebrahim Azemi; Jale Nilsaz; Reza Babapour; Mohammad Reza Haghdust
Journal:  Jundishapur J Nat Pharm Prod       Date:  2012-08-25

2.  Effectiveness of stop smoking interventions among adults: protocol for an overview of systematic reviews and an updated systematic review.

Authors:  Mona Hersi; Gregory Traversy; Brett D Thombs; Andrew Beck; Becky Skidmore; Stéphane Groulx; Eddy Lang; Donna L Reynolds; Brenda Wilson; Steven L Bernstein; Peter Selby; Stephanie Johnson-Obaseki; Douglas Manuel; Smita Pakhale; Justin Presseau; Susan Courage; Brian Hutton; Beverley J Shea; Vivian Welch; Matt Morrow; Julian Little; Adrienne Stevens
Journal:  Syst Rev       Date:  2019-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.